Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;44(5):562-571.
doi: 10.1002/pd.6558. Epub 2024 Mar 23.

Use of cell-free non-invasive prenatal testing in pregnancies affected by placental mosaicism

Ida Charlotte Bay Lund  1   2   3 , Naja Becher  1   2   3 , Dorte Lildballe  1   2   4   5 , Lotte Andreasen  1 , Simon Horsholt Thomsen  1   2   4 , Else Marie Vestergaard  1   2   6 , Ida Vogel  1   2   4   7
Affiliations

Use of cell-free non-invasive prenatal testing in pregnancies affected by placental mosaicism

Ida Charlotte Bay Lund et al. Prenat Diagn. 2024 May.

Abstract

Objective: To evaluate cell-free non-invasive prenatal testing (cfNIPT) in pregnancies affected by mosaicism.

Method: We assessed paired cfNIPT and chorionic villus sample (CVS) results from the same pregnancies in a case series of mosaicism detected in Central and North Denmark Regions from April 2014 to September 2018. Indications for the clinically obtained CVS, pregnancy markers and outcome were retrieved from The Danish Fetal Medicine Database.

Results: Mosaicisms in CVS involved common aneuploidy, n = 14; sex chromosomal aneuploidies, n = 14; rare autosomal trisomies (RATs), n = 16 and copy number variants (CNVs) >5Mb, n = 9. Overall, 24/53 (45.3%; CI 95%: 31.8%-59.4%) of cases with mosaicism were detected by cfNIPT; highest for RATs (56%) and lowest for CNVs (22%). CfNIPT more commonly detected high-level than low-level mosaic cases (p = 0.000). CfNIPT detected 7/16 (43.8%; CI 95%: 21%-69%) clinically significant mosaic cases, either true fetal mosaicism or confined placental mosaicisms with adverse pregnancy outcome. There was a trend toward a higher risk for adverse outcome in pregnancies where mosaicism was detected by cfNIPT compared to pregnancies where mosaicism was not detected by cfNIPT (p = 0.31).

Conclusion: CfNIPT has a low detection rate of mosaicism, including pregnancies with clinically significant mosaicism. However, abnormal cfNIPT results may be a predictor of adverse pregnancy outcomes.

PubMed Disclaimer

References

REFERENCES

    1. Gadsbøll K, Petersen OB, Gatinois V, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99(6):722‐730. https://doi.org/10.1111/aogs.13841
    1. Steffensen EH, Skakkebaek A, Gadsbøll K, et al. Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: a survey study. Prenat Diagn. 2023;43(2):144‐155. https://doi.org/10.1002/pd.6322
    1. Iwarsson E, Jacobsson B, Dagerhamn J, Davidson T, Bernabé E, Heibert Arnlind M. Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population ‐ a systematic review and meta‐analysis. Acta Obstet Gynecol Scand. 2017;96(1):7‐18. https://doi.org/10.1111/aogs.13047
    1. Mackie FL, Hemming K, Allen S, Morris R, Kilby M. The accuracy of cell‐free fetal DNA‐based non‐invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta‐analysis. BJOG An Int J Obstet Gynaecol. 2017;124(1):32‐46. https://doi.org/10.1111/1471‐0528.14050
    1. Taylor‐Phillips S, Freeman K, Geppert J, et al. Accuracy of non‐invasive prenatal testing using cell‐free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta‐analysis. BMJ. 2016;6(1):e010002. https://doi.org/10.1136/bmjopen‐2015‐010002

Publication types

LinkOut - more resources